TOBAM’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $205K | Buy |
528
+426
| +418% | +$165K | 0.08% | 113 |
|
|
2025
Q1 | $44K | Sell |
102
-332
| -76% | -$143K | 0.02% | 177 |
|
|
2024
Q4 | $160K | Buy |
434
+27
| +7% | +$9.95K | 0.05% | 173 |
|
|
2024
Q3 | $212K | Sell |
407
-72
| -15% | -$37.5K | 0.04% | 181 |
|
|
2024
Q2 | $260K | Sell |
479
-976
| -67% | -$530K | 0.04% | 163 |
|
|
2024
Q1 | $754K | Sell |
1,455
-86
| -6% | -$44.6K | 0.07% | 117 |
|
|
2023
Q4 | $727K | Sell |
1,541
-689
| -31% | -$325K | 0.06% | 107 |
|
|
2023
Q3 | $971K | Buy |
2,230
+75
| +3% | +$32.7K | 0.08% | 97 |
|
|
2023
Q2 | $957K | Sell |
2,155
-55
| -2% | -$24.4K | 0.07% | 107 |
|
|
2023
Q1 | $1.02M | Buy |
2,210
+637
| +40% | +$293K | 0.07% | 110 |
|
|
2022
Q4 | $807K | Buy |
1,573
+136
| +9% | +$69.8K | 0.05% | 117 |
|
|
2022
Q3 | $653K | Hold |
1,437
| – | – | 0.05% | 132 |
|
|
2022
Q2 | $693K | Buy |
1,437
+258
| +22% | +$124K | 0.04% | 149 |
|
|
2022
Q1 | $579K | Buy |
1,179
+422
| +56% | +$207K | 0.03% | 169 |
|
|
2021
Q4 | $351K | Hold |
757
| – | – | 0.02% | 162 |
|
|
2021
Q3 | $282K | Hold |
757
| – | – | 0.01% | 167 |
|
|
2021
Q2 | $289K | Sell |
757
-105
| -12% | -$40.1K | 0.01% | 172 |
|
|
2021
Q1 | $309K | Hold |
862
| – | – | 0.01% | 163 |
|
|
2020
Q4 | $277K | Hold |
862
| – | – | 0.01% | 168 |
|
|
2020
Q3 | $232K | Buy |
+862
| New | +$232K | 0.01% | 159 |
|
|
2019
Q4 | – | Sell |
-16,483
| Closed | -$3.96M | – | 119 |
|
|
2019
Q3 | $3.96M | Buy |
16,483
+505
| +3% | +$121K | 0.26% | 72 |
|
|
2019
Q2 | $4.51M | Buy |
+15,978
| New | +$4.51M | 0.25% | 70 |
|
|
2013
Q4 | – | Sell |
-80,792
| Closed | -$6.76M | – | 91 |
|
|
2013
Q3 | $6.76M | Sell |
80,792
-183,051
| -69% | -$15.3M | 0.38% | 56 |
|
|
2013
Q2 | $21.6M | Buy |
+263,843
| New | +$21.6M | 1.42% | 31 |
|